Tag: STAT+

April 13, 2026

Generic GLP-1s in India and FDA Drug Approval Withdrawals

April 12, 2026

Pharma and Biotech Career Moves: Ardelyx Appoints New CMO

April 11, 2026

FDA Again Rejects Replimune’s Advanced Skin Cancer Treatment

April 9, 2026

Ending the Clipboard: Medicare’s Health Tech Ecosystem Initiative

April 8, 2026

Progressive Think Tank Proposes Federal Control to Lower Health Care Costs

April 7, 2026

Medicare Advantage Insurers Win $13 Billion Pay Bump for 2027

April 5, 2026

Trump Administration Targets Pharma With New Tariffs and Pricing Deals

April 5, 2026

White House Proposes 12% Cut to HHS in 2027 Budget

April 4, 2026

Proxygen Appoints Chiara Conti as Chief Scientific Officer

April 4, 2026

White House Proposes $5 Billion Cut to NIH Budget for 2027

February 24, 2026

Medicare Payment Models & Health Outcomes: New Study Findings

February 24, 2026

Hims & Hers Earnings: GLP-1 Scrutiny & Weight Loss Future

February 23, 2026

Gilead to Acquire Arcellx for $7.8B in Cancer Therapy Deal

February 21, 2026

FDA Scrutiny of Antidepressants & RSV Shots, Antibiotic Production Shifts – Week in Pharma News

February 21, 2026

OhioHealth Sued by DOJ for Alleged Anti-Competitive Practices

February 21, 2026

Cancer Immunotherapy Study Faces Data Integrity Concerns | STAT News